Navigation Links
Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab
Date:11/10/2008

CAMBRIDGE, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present at Deutsche Bank's 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET.

The live and archived webcast of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
2. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
3. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
4. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
5. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
6. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
9. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
10. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire-FirstCall/ -- Sigma-Aldrich Corporation (...MX conference on Tuesday, December 1st at 1:45 PM ...may listen via live audio broadcast over the Inter...a ldrich.com/ . Users can click the "Webcast" i...rich: Sigma-Aldrich is a leading Life Science an...
(Date:11/24/2009)...v. 24 NeurogesX, Inc. (N...d on developing and commercializing novel pain man...Tonno, President and Chief Executive Officer, is s...ay Health Care Conference, to be held December 1-2...ew York. ,, Mr. DiTonno and Stephen Ghiglieri,...
(Date:11/24/2009)...dpoint has been met for patients with advanced-sta...BEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna...mpany"), a global biopharmaceutical company focuse...ed positive efficacy data from a Phase 2 study wit...08 (formerly AN-152), in patients with advanced or...
(Date:11/24/2009)...ov. 24 Genomic Health, I...ott, Genomic Health,s Executive Chairman, will pre...Conference in New York City on Tuesday, December 1... and subsequently archived webcast of the presenta...mic Health,s website at http://investor.genomiche...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ewswire-FirstCall/ - Nventa,Biopharmaceuticals Cor...ny,has completed enrollment and initiated dosing o...e escalation trial examining the safety of its,lea...lasia, a precursor to,cervical cancer. HspE7 is an...an papillomavirus (HPV)-related diseases. Patients...
...has been growing interest in the question, if the ...soils via manure application is of environmental r...mber issue of the journal CLEAN, Kreuzig and co-wo...benzimidazole antiparasitics, adding valuable data...vior of veterinary medicinal products in manure an...
...can Society of,Hematology (ASH), the world,s large...expects more than 20,000 attendees at the 49th ASH...rgia World Congress Center in,Atlanta. The meeting...for,blood disorders., "The ASH annual meeting is ...rom around the world to hear the most up-to-date d...
Other Biology Technology:Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 2Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 3Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 4Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 5New insights into the fate of anti-parasitics in manure and manured soils 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 3
(Date:11/24/2009)...of Medical Toxicology (ACMT) have signed an agreem...nal of Medical Toxicology (JMT), the official jou... previously published by the University of Pennsyl...gy , an international, peer-reviewed journal, is d...medical toxicology. The quarterly journal focuses...
(Date:11/24/2009)...atter of debate. A high-profile study a few years ...heir carbon from trees and leaves, evidence for a ...c ecosystems. , But new research from the Univer...true. Algae provide a much richer diet for fish an...hed this week in the Proceedings of the National ...
(Date:11/23/2009)...rong evidence that the "synergistic" effect of ear...ollution and indoor endotoxin causes more harm to ...one. , Environmental health scientists at the ...have shown that children exposed to both high leve...in during early life are six times more likely to ...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 1Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 3Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 4Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 1Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3
...mplicated in human cancers, researchers from White...nology report in the February 22nd online issue of...t can repress activity of a gene by targeting the ... and starts the process of protein production). ...worms. It took seven years for the second one to b...
...betes, lupus and rheumatoid arthritis occur when t...earchers have not known precisely where the molecu.... Now, a team of scientists from the Whitehead Ins...dentified a key set of genes that lie at the core ...ntists develop new methods for manipulating immune...
... or chicken fillet every now and again could add a...hown for the first time that food enriched with na...ore resistant to the processes of ageing. The conc... hope that the same concept can help extend human ...ses of ageing, reports Marina Murphy in Chemistry ...
Other Biology News:MicroRNA helps prevent tumors 2MicroRNA helps prevent tumors 3Cracking open the black box of autoimmune disease 2Meat and two neutrons -- the key to a longer life 2
Rat Anti-Mouse Reticular Fibroblast (pan) Monoclonal Antibody, Unconjugated, Clone ER-TR7 from CEDARLANE Laboratories Limited
Mouse Anti-BCAR1 Monoclonal Antibody, Unconjugated, Clone SPM302 from Abcam
Mouse Anti-Human p21 Ras Monoclonal Antibody, Unconjugated, Clone NCC-RAS-001 from ABR-Affinity BioReagents
Rabbit Anti-GPCR G2A Polyclonal Antibody, Unconjugated from Abcam
Biology Products: